Viral Hepatitis C - Body parts scandal raises critical questions

Body parts scandal raises critical questions
Burlington Free Press - The list of Vermonters affected by a national scandal involving stolen body parts continues to grow, with three Vermont hospitals and three dental surgery facilities notified as recently as Monday of patients who might have received questionable

Antibodies Neutralizing Peginterferon Alfa during Retreatment of
New England Journal of Medicine - To the Editor: Peginterferons are widely used to treat chronic hepatitis C virus (HCV) infection, an important cause of liver cirrhosis and hepatocellular carcinoma. 1 , 2 , 3 , 4 We describe a patient who did not have a virologic response to

Human Genome tumbles on mixed drug data
Investors Business Daily - BOSTON (MarketWatch) -- Human Genome Sciences shares tumbled Tuesday following the release of mixed Phase II clinical data for its biologic drug candidate to treat hepatitis C, Albuferon. Shares of Human Genome sank 20% to close at $10.89. In a

Screening test available to detect an antibody to hepatitis C
Inside Bay Area - This is the fourth in a series of columns on medical conditions that are hard to diagnose in women. To read last week's column, visit insidebayarea.com, click on "health" and then click on the headline for "Knowing the warning signs for cervical

CytoDyn CEO Explains Company's Strategy to Prevent Drug-Resistant
Financial News USA - City of Industry, CA --(www.FinancialNewsUSA.com)-- 03/21/2006 - Pharmaceuticals industry news provided by Financial News USA (OTC: FNWU) A recent meeting of the New Mexico Biotechnology & Biomedical Association featured a talk by Allen D. Allen, CEO